<!DOCTYPE html>
<html lang="en">

<head>
    <title>CET</title>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="icon" href="images/hmslogo.ico" type="image/vnd.microsoft.icon">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <link href="https://fonts.googleapis.com/css?family=Montserrat&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="css/open-iconic-bootstrap.min.css">
    <link rel="stylesheet" href="css/animate.css">


    <link rel="stylesheet" href="css/owl.carousel.min.css">
    <link rel="stylesheet" href="css/owl.theme.default.min.css">
    <link rel="stylesheet" href="css/magnific-popup.css">

    <link rel="stylesheet" href="css/aos.css">

    <link rel="stylesheet" href="css/ionicons.min.css">

    <link rel="stylesheet" href="css/bootstrap-datepicker.css">
    <link rel="stylesheet" href="css/jquery.timepicker.css">


    <link rel="stylesheet" href="css/flaticon.css">
    <link rel="stylesheet" href="css/icomoon.css">
    <link rel="stylesheet" href="css/style.css">
</head>

<body>

    <nav class="navbar navbar-expand-lg navbar-dark ftco_navbar bg-dark ftco-navbar-light" id="ftco-navbar">
        <div class="container">
            <a class="navbar-brand" href="index.html"><img src="images/newlogo.png" /></a>
            <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#ftco-nav"
                aria-controls="ftco-nav" aria-expanded="false" aria-label="Toggle navigation">
                <span class="oi oi-menu"></span> Menu
            </button>

            <div class="collapse navbar-collapse" id="ftco-nav">
                <ul class="navbar-nav ml-auto">
                    <li class="nav-item active"><a href="index.html" class="nav-link"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            style="text-transform: capitalize;">Home</a></li>
                    <li class="nav-item active"><a href="research.html" class="nav-link"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            style="text-transform: capitalize;">Research</a></li>
                    <li class="nav-item active"><a href="publications.html" class="nav-link"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            style="text-transform: capitalize;">Publications</a></li>
                    <li class="nav-item active dropdown">
                        <a class="nav-link dropdown-toggle" href="team.html" id="navbarDropdown" role="button"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"
                            style="text-transform: capitalize;">
                            People
                        </a>
                        <div class="dropdown-menu" aria-labelledby="navbarDropdown">
                            <a class="dropdown-item" href="pi.html" onMouseOver="this.style.color='#A41034'"
                                onmouseout="this.style.color='black'">Principal Investigators</a>
                            <a class="dropdown-item" href="researchers.html" onMouseOver="this.style.color='#A41034'"
                                onmouseout="this.style.color='black'">Senior Researchers</a>
                            <a class="dropdown-item" href="students.html" onMouseOver="this.style.color='#A41034'"
                                onmouseout="this.style.color='black'">Student Researchers</a>
                            <a class="dropdown-item" href="alumni.html" onMouseOver="this.style.color='#A41034'"
                                onmouseout="this.style.color='black'">Alumni</a>
                        </div>
                    </li>
                    <li class="nav-item active"><a href="contact.html" class="nav-link"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            style="text-transform: capitalize;">Contact</a></li>
                    <li class="nav-item active"><a href="joinus.html" class="nav-link"
                            onMouseOver="this.style.color='#A41034'" onmouseout="this.style.color='black'"
                            style="text-transform: capitalize;">Join
                            Us</a></li>
                </ul>
            </div>
        </div>
    </nav>
    <!-- END nav -->
    <br><br><br><br>
    <img src="images/research.jpg" alt="Group Photo" width=100%>
    <br><br>
    <h1>
        <center>RESEARCH</center>
    </h1>
    <p style=" color: black; margin-left: 20%; margin-right: 20%; text-align: justify; font-size: larger;"> At a
        fundamental level, we are
        currently working on three different themes: the early events of metastasis; understanding the mechanisms (such
        as phenotypic plasticity) that allow cancer cells to tolerate chemotherapy; and developing next generation
        therapeutics, including nanomedicines, that can modulate the tumor stromal contexture, including the immune
        cells.
    </p>



    <br><br><br>



    <div class="l_col">
        <img src="images/Figure_cancer_new.png" width=100%>
    </div>
    <div class="r_col">
        <p style=" color: black; margin: 0%; padding-top: 0%;">
            <h2><b>Cancer Immunology</b></h2>
            <p style="text-align: justify; margin: 0%; padding-top: 0%;">
                We are exploring new frontiers in using the immune system to target cancer.
                We are studying the mechanisms underlying the interactions between cancer and immune cells. We
                demonstrated, for the first time, that the dual targeting of SIRP and CSF1R using a novel engineered
                therapeutic allows macrophages to better phagocytose cancer cells (Nature Biomedical Engineering, 2018).
                We were the first to design an activatable reporter nanoparticle to monitor the anti-cancer efficacy of
                an immune checkpoint inhibitor in real-time (PNAS 2016).Using microfluidics platforms and tumor
                explants, we are studying how immune cells be recruited into tumors. We are also exploring the roles of
                B cells in tumor immune response. Using a computational design platform, we recently designed a new
                linker for engineering antibody drug conjugates for treatment of cancer (Nature Biomedical Engineering,
                2019).
            </p>
        </p>
    </div>
    <div style="clear:both" />

    <br>
    <br>

    <div class="r_col">
        <img src="images/Figure_nanomedicine.jpg" width=100% >
    </div>
    <div class="l_col">
        <p style="float:left; color: black; margin-left:0 ; width: 100%; margin: 0%; padding-top: 0%;">
            <b>
                <h2>Nanomedicine</h2>
            </b>
            <p style="text-align: justify; margin: 0%;">
                We are pioneering the use of nanoheight="330px"technology to unravel new concepts in biology and
                medicine.
                We were the first to design layer by layer nanoparticles, inspired by the need to sequentially target
                different compartments of a tumor (Nature 2005). Using imaging techniques that allowed us to visualize
                nanoscale structures, we demonstrated that cancer cells can modify stromal cells in a tumor by
                physically communicating through tunneling nanotubes (Nature Communications, 2015). We have merged
                mathematical modeling and cancer biology to understand how cancer cells exhibit phenotypic plasticity
                and drug tolerance, and designed next generation nanomedicines to perturb these phenomenon (Nature
                Commun. 2015, ACS Nano 2016, Science Signaling, 2019). We are curious to explore fundamental questions
                around dormancy, metastasis, treatment failures, etc, using technologies at the nanoscale.
            </p>
        </p>
    </div>
    <div style="clear:both" />
    <br>
    <br>

    <div class="l_col">
        <img src="images/Figure_biomaterial.png" width=100% >
    </div>

    <div class="r_col">
        <p style=" color: black; margin: 0%; padding-top: 0%;">
            <h2><b>Biomaterials</b></h2>
            <p style="text-align: justify; margin: 0%;">
                We develop innovative biomaterials that can be used to treat injuries or replace damaged tissues. We
                have recapitulated the composition and structure of bone at the nanoscale by establishing synthetic
                methods for hydroxyapatite and whitlockite bone crystals, the two major bone minerals in the human body,
                and forming hierarchical nanochannels in bone scaffolds. For the first time, we reported a facile
                synthetic method of whitlockite nanoparticles and demonstrated how whitlockite has different material
                property from hydroxyapatite, which led whitlockite to exhibit enhanced osteogenic capacity than
                hydroxyapatite. Based on these nanomaterials, we have developed bone implants and spine implants that
                can function <i>in vivo</i>.
            </p>
        </p>
    </div>


    <div style="clear:both" />
    <br><br>

    <div class="r_col">
        <img src="images/Figure_tissueEng.png" width=100% >
    </div>
    <div class="l_col">
        <p style="float:left; color: black;  width: 100%; text-align: justify;margin: 0%; padding-top: 0%;">
            <b>
                <h2>Tissue engineering and modeling/simulation of biological phenomena.</h2>
            </b>
            <p style="text-align: justify; margin: 0%;">
                We design and tune 3D composite scaffolds to provide an optimal microenvironment for encapsulated cells
                to differentiate into a specific direction and develop tissue. By orchestrating different types of
                cells, we can control the spatial distribution of cellular structure in 3D tissue scaffold.
                As blood circulation is critical during tissue regeneration by supplying oxygen, nutrients, and cells,
                we have also successfully recapitulated perfusable microvasculature in 3D tissue scaffolds. We have
                engineered vascularized tissues on microfluidic chips which can be used for testing novel drugs and
                investigate pathological mechanisms of various diseases including cancer metastasis.
                Since each tissue dynamically interacts with other neighboring tissues, we have been using holistic and
                interdisciplinary approach to engineer complex organ systems, including usage of 3D bioprinting
                technology. At the same time, we regulate different types of biomaterials for directing cellular growth
                and differentiation as cells of each tissue type seeks their niche with distinct physicochemical
                properties.
            </p>

        </p>
    </div>
    <div style="clear:both" />


    <br>





    <!-- loader -->
    <div id="ftco-loader" class="show fullscreen"><svg class="circular" width="48px" height="48px">
            <circle class="path-bg" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke="#eeeeee" />
            <circle class="path" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke-miterlimit="10"
                stroke="#F96D00" /></svg></div>

    <br><br><br>

    <div class="row">
    </div>

    <br><br>

    <footer class="ftco-footer ftco-bg-dark ftco-section img" style="">
        <div class="container">
            <div class="row mb-5">
                <div class="col-md">
                    <div class="ftco-footer-widget mb-4 bg-primary p-4">
                        <h2 class="ftco-heading-2">Center For Engineered Therapeutics</h2>
                        <p></p>
                        <ul class="ftco-footer-social list-unstyled mb-0">

                            <li class="ftco-animate"><a href="https://linkedin.com"><span
                                        class="icon-linkedin"></span></a></li>
                            <li class="ftco-animate"><a href="https://twitter.com"><span
                                        class="icon-twitter"></span></a></li>
                            <li class="ftco-animate"><a href="https://facebook.com"><span
                                        class="icon-facebook"></span></a></li>
                        </ul>
                    </div>
                </div>

                <div class="col-md">
                    <div class="ftco-footer-widget mb-4">
                        <h2 class="ftco-heading-2">Quick Links</h2>
                        <ul class="list-unstyled">
                            <li><a href="index.html" class="py-2 d-block">Home</a></li>
                            <li><a href="index.html#about" class="py-2 d-block">About</a></li>
                            <li><a href="research.html" class="py-2 d-block">Research</a></li>
                            <li><a href="publications.html" class="py-2 d-block">Publication</a></li>
                            <li><a href="team.html" class="py-2 d-block">People</a></li>
                            <li><a href="joinus.html" class="py-2 d-block">Join Us</a></li>
                        </ul>
                    </div>
                </div>
                <div class="col-md">
                    <div class="ftco-footer-widget mb-4">
                        <h2 class="ftco-heading-2">Office</h2>
                        <div class="block-23 mb-3">
                            <ul>
                                <li><span class="icon icon-map-marker"></span><span class="text"><a
                                            href="https://www.google.com/maps?ll=42.360618,-71.100791&z=16&t=m&hl=en&gl=US&mapclient=embed&q=65+Landsdowne+St+Cambridge,+MA+02139">
                                            Brigham and
                                            Women's Hospital,<br> 65 Landsdowne street, Rm 317, Cambridge, MA 02133</a>
                                    </span> </li>
                                <li><a href="mailto:shiladit@mit.edu"><span class="icon icon-envelope"></span><span
                                            class="text">shiladit(at)mit.edu</span></a></li>
                                <li><a href="mailto:haelin@mit.edu"><span class="icon icon-envelope"></span><span
                                            class="text">haelin(at)mit.edu</span></a></li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            <div class="row">
                <div class="col-md-12 text-center">
                    <p>Copyright © 2019 Center For Engineered Therapeutics | All rights reserved</p>
                </div>
            </div>
        </div>
    </footer>

    <script src="js/jquery.min.js"></script>
    <script src="js/jquery-migrate-3.0.1.min.js"></script>
    <script src="js/popper.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/jquery.easing.1.3.js"></script>
    <script src="js/jquery.waypoints.min.js"></script>
    <script src="js/jquery.stellar.min.js"></script>
    <script src="js/owl.carousel.min.js"></script>
    <script src="js/jquery.magnific-popup.min.js"></script>
    <script src="js/aos.js"></script>
    <script src="js/jquery.animateNumber.min.js"></script>
    <script src="js/bootstrap-datepicker.js"></script>
    <script src="js/jquery.timepicker.min.js"></script>
    <script src="js/scrollax.min.js"></script>
    <script
        src="https://maps.googleapis.com/maps/api/js?key=AIzaSyBVWaKrjvy3MaE7SQ74_uJiULgl1JY0H2s&sensor=false"></script>
    <script src="js/google-map.js"></script>
    <script src="js/main.js"></script>

</body>

</html>